To ask the Secretary of State for Health, if he will take steps to ensure that the FreeStyle Libre Flash Glucose Monitoring system is accessible to all diabetes patients
Answered on
1 December 2017
Freestyle Libre has been approved for reimbursement on National Health Service prescription from 1 November through listing in Part IX of the Drug Tariff. The Drug Tariff is a price list that covers England and Wales, and the listing of a medical device in the Tariff should not be interpreted as a recommendation to prescribe a particular product. Patients will need to discuss the ongoing management of their condition with their healthcare professional and consider whether flash glucose monitoring is suitable for them.
Answered by
Department of Health and Social Care